These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17510307)

  • 21. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
    Fowkes FJ; Richards JS; Simpson JA; Beeson JG
    PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.
    Addai-Mensah O; Seidel M; Amidu N; Maskus DJ; Kapelski S; Breuer G; Franken C; Owusu-Dabo E; Frempong M; Rakotozandrindrainy R; Schinkel H; Reimann A; Klockenbring T; Barth S; Fischer R; Fendel R
    Malar J; 2016 Feb; 15():65. PubMed ID: 26850066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.
    Stowers AW; Kennedy MC; Keegan BP; Saul A; Long CA; Miller LH
    Infect Immun; 2002 Dec; 70(12):6961-7. PubMed ID: 12438375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired antibodies to merozoite antigens in children from Uganda with uncomplicated or severe Plasmodium falciparum malaria.
    Ahmed Ismail H; Ribacke U; Reiling L; Normark J; Egwang T; Kironde F; Beeson JG; Wahlgren M; Persson KE
    Clin Vaccine Immunol; 2013 Aug; 20(8):1170-80. PubMed ID: 23740926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria.
    Reddy SB; Anders RF; Beeson JG; Färnert A; Kironde F; Berenzon SK; Wahlgren M; Linse S; Persson KE
    PLoS One; 2012; 7(2):e32242. PubMed ID: 22363818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C; Ubillos I; Jairoce C; Gyan B; Vidal M; Jiménez A; Santano R; Dosoo D; Nhabomba AJ; Ayestaran A; Aguilar R; Williams NA; Díez-Padrisa N; Lanar D; Chauhan V; Chitnis C; Dutta S; Gaur D; Angov E; Asante KP; Owusu-Agyei S; Valim C; Gamain B; Coppel RL; Cavanagh D; Beeson JG; Campo JJ; Moncunill G
    BMC Med; 2019 Aug; 17(1):157. PubMed ID: 31409398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
    Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory.
    Clark EH; Silva CJ; Weiss GE; Li S; Padilla C; Crompton PD; Hernandez JN; Branch OH
    Infect Immun; 2012 Apr; 80(4):1583-92. PubMed ID: 22252876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
    Metzger WG; Okenu DM; Cavanagh DR; Robinson JV; Bojang KA; Weiss HA; McBride JS; Greenwood BM; Conway DJ
    Parasite Immunol; 2003 Jun; 25(6):307-12. PubMed ID: 14507328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
    Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
    Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of natural antibodies against Plasmodium falciparum 83-kilodalton apical membrane antigen (PF83/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83/AMA-1.
    Thomas AW; Trape JF; Rogier C; Goncalves A; Rosario VE; Narum DL
    Am J Trop Med Hyg; 1994 Dec; 51(6):730-40. PubMed ID: 7810805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.
    Elias SC; Choudhary P; de Cassan SC; Biswas S; Collins KA; Halstead FD; Bliss CM; Ewer KJ; Hodgson SH; Duncan CJ; Hill AV; Draper SJ
    Immunology; 2014 Apr; 141(4):628-44. PubMed ID: 24303947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of avidity maturation of merozoite antigen-specific antibodies with increasing exposure to Plasmodium falciparum amongst children and adults exposed to endemic malaria in Kenya.
    Ibison F; Olotu A; Muema DM; Mwacharo J; Ohuma E; Kimani D; Marsh K; Bejon P; Ndungu FM
    PLoS One; 2012; 7(12):e52939. PubMed ID: 23300828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.